Altos Labs
Claimed
Agent56 out of 100, Top 25%. Agent Readiness. Open the scores section.Agent Readiness: 56/100. Top 25%. Measured by StartupHub.ai. Median 41.Trust80 out of 100, Top 25%. Data Trust. Open the scores section.Data Trust: 80/100. Top 25%. Measured by StartupHub.ai. Median 61.Biotechnology company focused on cellular rejuvenation to reverse disease and extend healthspan.
About
Altos Labs is a biotechnology company dedicated to unraveling the deep biology of cellular rejuvenation programming. Their mission is to restore cell health and resilience to reverse disease, injury, and disabilities, aiming to transform medicine and extend human healthspan. They bring together leading scientists, clinicians, and industry leaders in a collaborative environment.
Listed competitors
Also in this space
Developing novel therapies to reverse aging and extend lifespan.
Shares Biotechnology, Longevity
Biotechnology company developing novel therapeutics to promote healthy longevity by understanding aging pathways.
Shares HealthTech, Longevity
Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
Shares Biotechnology, Genomics
AI biologist platform accelerating preclinical drug development by integrating biological data for smarter decisions.
Shares Biotechnology, HealthTech
Developing epigenetic reprogramming drugs for age restoration.
Shares Biotechnology, Longevity
“The first anti-aging therapy is entering clinical trials. The epigenetic reprogramming from Life Biosciences is in works. Here is…” r/immortalists
Decoding the immune system to pioneer a paradigm shift in disease diagnosis and treatment.
Shares Biotechnology, HealthTech
Key facts
- Website
- altoslabs.com
- Headquarters
- Redwood City, United States
- Founded
- 2021
- Employees
- 566
- Total funding
- $3.8B (Series B)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Post-money | Lead investors |
|---|---|---|---|---|
| 1 Jan 2022 | Series B | $800M | $3.3B | Arch Venture Partners |
| 1 Feb 2021 | Series A | $3.0B | Arch Venture Partners |
Tech stack
Detected on altoslabs.com, last scanned 18 Sept 2026. Run your own scan
- Frontend
- Next.js, Tailwind CSS
- CDN
- Vercel
- Email provider
- Google Workspace
Test your Ahrefs DR
The backlink strength of a domain, on the Ahrefs 0 to 100 scale. About a minute.
Frequently asked
Is Altos Labs trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Altos Labs is 80 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Altos Labs raised?
Altos Labs has raised a total of $3.8B in funding. The most recent round on record is Series B.
How many employees does Altos Labs have?
Altos Labs has approximately 566 people on record.
SEC filings, insider activity, nonprofit links and pay benchmarks for Altos Labs:
Company details: from public sources. Funding: no announced round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules
